GPR55 regulates the responsiveness to, but does not dimerise with, α


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
06 2021
Historique:
received: 28 01 2021
revised: 26 03 2021
accepted: 06 04 2021
pubmed: 13 4 2021
medline: 15 9 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

Emerging evidence suggests that G protein coupled receptor 55 (GPR55) may influence adrenoceptor function/activity in the cardiovascular system. Whether this reflects direct interaction (dimerization) between receptors or signalling crosstalk has not been investigated. This study explored the interaction between GPR55 and the alpha 1A-adrenoceptor (α

Identifiants

pubmed: 33844984
pii: S0006-2952(21)00156-8
doi: 10.1016/j.bcp.2021.114560
pii:
doi:

Substances chimiques

Adrenergic alpha-1 Receptor Agonists 0
GPR55 protein, mouse 0
Receptors, Adrenergic, alpha-1 0
Receptors, Cannabinoid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114560

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Sarah K Walsh (SK)

Cardiometabolic Health Research, School of Pharmacy and Life Sciences, Robert Gordon University, Sir Ian Wood Building, Aberdeen AB10 7GJ, UK. Electronic address: s.walsh@rgu.ac.uk.

Christopher Lipina (C)

Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.

Sheng Y Ang (SY)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Masaaki Sato (M)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Ling Yeong Chia (LY)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Martina Kocan (M)

The Florey Institute of Neuroscience and Mental Health and School of Biosciences, University of Melbourne, Parkville, VIC, Australia.

Dana S Hutchinson (DS)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Roger J Summers (RJ)

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Cherry L Wainwright (CL)

Cardiometabolic Health Research, School of Pharmacy and Life Sciences, Robert Gordon University, Sir Ian Wood Building, Aberdeen AB10 7GJ, UK.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH